Clinical Trial Governance A Strategic Look At KPIs From An RTSM Perspective

Effective governance in clinical trials hinges on more than meeting timelines — it requires a strategic approach to performance measurement. Key performance indicators (KPIs) serve as the backbone for evaluating trial health, but their true value emerges when aligned with Randomization and Trial Supply Management (RTSM) systems. Metrics such as enrollment velocity, drug dispensation accuracy, and site compliance provide actionable insights that help sponsors anticipate risks and optimize resource allocation.

By leveraging RTSM data, teams can move beyond reactive reporting to proactive decision-making, ensuring supply continuity and patient safety across global studies. This governance model not only strengthens operational oversight but also accelerates trial execution without compromising quality. Explore how integrating RTSM-driven KPIs into governance frameworks transforms oversight into a strategic advantage.

Access the full resource to learn which KPIs matter most and how to apply them effectively in your governance strategy.